Feb 16, 2023 / 05:00PM GMT
David Reed Risinger - SVB Securities LLC, Research Division - Senior MD
Great. Good morning, everybody. So thanks very much for joining us for this next session with Eli Lilly. On behalf of SVB Securities, it's very much my pleasure to welcome Ilya Yuffa, who is Executive Vice President and President of Lilly International Operations. So Ilya, I thought it would be great to have you start off with some opening comments given the phenomenal momentum that Lilly has, and then we'll dive into Q&A.
Ilya Yuffa - Eli Lilly and Company - Senior VP & President of Lilly International
Sounds good. Well, Dave, great to see you, and thank you for hosting and interest in Lilly. Just for perspective, this is a pretty exciting year for Lilly and Lilly International. There's -- there are a number of components, as I think about our fundamentals of our growth brands that we currently see roughly more than 2/3 of our business coming from our growth brands currently. And that's in advance of launching in a number of new spaces.
And so this year really is an
Eli Lilly and Co at SVB Securities Global Biopharma Conference (Virtual) Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers